Article information
Full text is only aviable in PDF
Bibliografía
[1.]
V.V. Kakkar, B. Djazaeri, J. Fok, M. Fletcher, M.F. Scully, J. Westwick.
Low molecular weight heparin in the prophylaxis of venous thrombosis.
Br Med J, 284 (1982), pp. 375-379
[2.]
J. Hirsh.
Heparin.
N Engl J Med, 324 (1991), pp. 1.565-1.574
[3.]
M. Verstraete.
Pharmacotherapeutic aspects of unfractionen and low molecular weight heparins.
Drugs, 40 (1990), pp. 498-530
[4.]
C.J. Carter, J.G. Kelton, J. Hirsh, A. Cerskus, A.V. Santos, M. Gent.
The relationship between the hemorragic and antithrombotic properties of low molecular heparin in rabbits.
Blood, 59 (1982), pp. 1.239-1.245
[6.]
S. Haas, P. Haas.
Efficacy of low molecular weight heparins: an overview.
Semin Thromb Hemost, 19 (1993), pp. 101-106
[7.]
D. Bergqvist.
Perioperative hemorrhagic complications in patients on low molecular weight heparins.
Semin Thromb Hemost, 19 (1993), pp. 128-130
[8.]
V.V. Kakkar, A.T. Cohen, R.A. Edmonson, M.J. Phillips, D.J. Cooper, S.K. Das, et al.
Low molecular weight heparin for prevention fo venous thromboembolism after major abdominal surgery.
Lancet, 341 (1993), pp. 259-265
[9.]
O. Huber, H. Bounameaux, F. Bosrt, A. Rohner.
Postoperative pulmonary embolism after hospital discharge.
An underestimated risk. Arch Surg, 127 (1992), pp. 310-313
[10.]
S. Haas, C.W. Flosbach.
Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
Semin Thromb Hemost, 19 (1993), pp. 164-173
[11.]
E. Melissari, C.J. Parker, N.V. Wilson, G. Monte, C. Kanthou, K.D. Pemberton, et al.
Use of low molecular weight heparin in pregnancy.
Thromb Haemost, 68 (1992), pp. 652-656
[12.]
European consensus statement.
Prevention of venous thromboembolism.
Internat Angiol, (1992), pp. 151-159
[13.]
G. Bratt, E. Tornebohm, S. Ganqvist, W. Aberg, D. Lodkner.
A comparison between low molecular weight heparin (Kabi2165) and standard heparin in the intravenous treatment of deep vein thrombosis.
Thromb Haemost, 54 (1985), pp. 813-817
[14.]
J. Albada, N.K. Nieuwenhuis, J.J. Sixma.
Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmín).
Results of a double-blind randomized study. Circulation, 80 (1989), pp. 935-940
[15.]
G. Bratt, W. Aberg, M. Johansson, E. Törnebohm, S. Granqvist, D. Lockner.
Two daily subcutaneous injections of Fragmín as compared with intravenous standard heparin in the treatment of deep venous thrombosis.
Thromb Haemost, 64 (1990), pp. 506-510
[16.]
A., collaborative European multicentre study.
A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep venous thrombosis.
Thromb Haemost, 65 (1991), pp. 251-256
[17.]
C. Théry, G. Simonneau, G. Meyer, O. Hélénon, F. Bridey, C. Armagnac, et al.
Randomized trial of subcutaneous low-molecularweight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
Circulation, 85 (1992), pp. 1.380-1.389
[18.]
P. Prandoni, A.W.A. Lensing, H.R. Büller, M.R. Carta, A. Cogo, M. Vigo, et al.
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deepvein thrombosis.
Lancet, 339 (1992), pp. 441-445
[19.]
S. Lopaciuk, A.J. Meissner, S. Filipecki, K. Zawilska, J. Sowier, L. Ciesielski, et al.
Subcutaneous low molecular weight heparin versus subcutaneous unfractioned heparin in th treatment of deep vein thrombosis: a polish multicenter trial.
Thromb Haemost, 68 (1992), pp. 14-18
[20.]
G. Simonneau, B. Charbonnier, H. Decousus, B. Planchon, J. Ninet, P. Sie, et al.
Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Arch Intern Med, 153 (1993), pp. 1.541-1.546
[21.]
R.D. Hull, G.E. Raskob, G.F. Pineo, D. Green, A.A. Trowbridge, C.G. Elliott, et al.
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
N Engl J Med, 326 (1992), pp. 975-982
[22.]
M. Monreal, E. Lafoz, A. Olive, L. Del Río, C. Vedia.
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmín) in patients with venous thromboembolism and contraindications to Coumarin.
Thromb Haemost, 71 (1994), pp. 7-11
[23.]
J. Fareed, D.A. Hoppensteadt, J.M. Walenga.
Current perspectives on low molecular weight heparins.
Semin Thromb Haemost, 19 (1993), pp. 1-11
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
